NCT03708874

Brief Summary

Patients diagnosed with acute cholecystitis benefit from emergency laparoscopic cholecystectomy (LC). Patients who had emergency LC showed improvement in quality of life in one month compared to those treated. Delayed LC (after the acute cholecystitis has passed) and less time to recover from work. This strategy reduces the risk of repeated referrals with more pain or pancreatitis. There are many studies on the efficacy of intraoperative intraperitoneal bupivacaine(IPBV) with elective LC on pain of IPBV. However, the prospective study of reducing the postoperative pain of emergency LC - IPBV is very few. This study will be conducted to evaluate the efficacy of IPBV in patients with emergency LC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

October 9, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 17, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2019

Completed
Last Updated

August 22, 2019

Status Verified

August 1, 2019

Enrollment Period

3 months

First QC Date

October 9, 2018

Last Update Submit

August 21, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-operative Shoulder Pain

    Group 1 and Group 2 Post-operative shoulder pain. VAS score ;Explain to the person that each number describe the intensity of his pain. Number 0 describe very happy and no pain and no hurt at all. Number 1 hurts just a little bit. And as te numbers gradually increase pain will increase. Number 10 describes the worst pain in his life. Ask the patient to choose the number that best describes how he is feeling and his pain.

    postoperative 1st day

Secondary Outcomes (8)

  • Post-operative Abdominal Pain 2nd Hour

    pain at postoperative 2nd hour

  • operation time

    up to 100 minutes

  • Change in C -reactive protein (CRP) level in all study participants

    preoperative and postoperative 1st day

  • Change in alanine aminotransferase (ALT) level in all study participants

    preoperative and postoperative 1st day

  • Change in Aspartate Aminotransferase (AST) level in all study participants

    preoperative and postoperative 1st day

  • +3 more secondary outcomes

Study Arms (2)

Group 1.Intraoperative bupivacaine

intraperitoneal bupivacaine wash-emergency laparoscopic cholecystectomy

Group 2.Intravenous paracetamol

intravenous paracetamol-emergency laparoscopic cholecystectomy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient aged 18-70 years diagnosed with ASA I, II and III acute cholecystitis

You may qualify if:

  • Acute stone cholecystitis
  • Acute acrylic cholecystitis

You may not qualify if:

  • Cholecystitis with chronic stones
  • Gallbladder polyps,
  • Patients with bleeding diathesis,
  • Allergy to local anesthetic agents,
  • Patients with paracetamol group allergy,
  • Choledocholithiasis associated with acute cholecystitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Turgut Donmez

Istanbul, 34300, Turkey (Türkiye)

Location

Related Publications (3)

  • Gurusamy KS, Nagendran M, Toon CD, Guerrini GP, Zinnuroglu M, Davidson BR. Methods of intraperitoneal local anaesthetic instillation for laparoscopic cholecystectomy. Cochrane Database Syst Rev. 2014 Mar 25;2014(3):CD009060. doi: 10.1002/14651858.CD009060.pub2.

  • Kaushal-Deep SM, Anees A, Khan S, Khan MA, Lodhi M. Randomized controlled study of intraincisional infiltration versus intraperitoneal instillation of standardized dose of ropivacaine 0.2% in post-laparoscopic cholecystectomy pain: Do we really need high doses of local anesthetics-time to rethink! Surg Endosc. 2018 Jul;32(7):3321-3341. doi: 10.1007/s00464-018-6053-z. Epub 2018 Jan 16.

  • Roberts KJ, Gilmour J, Pande R, Hodson J, Lam FT, Khan S. Double-blind randomized sham controlled trial of intraperitoneal bupivacaine during emergency laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):310-6. doi: 10.1016/s1499-3872(13)60049-1.

MeSH Terms

Conditions

Abdominal PainShoulder PainPersonal Satisfaction

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, DigestiveArthralgiaJoint DiseasesMusculoskeletal DiseasesBehavior

Study Officials

  • Turgut Donmez, surgeon

    Bakirkoy Training and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Mehmet Emin Gunes, MD

    Bakirkoy Training and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 9, 2018

First Posted

October 17, 2018

Study Start

October 9, 2018

Primary Completion

January 9, 2019

Study Completion

March 14, 2019

Last Updated

August 22, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

After the patients are included in the study, the patient data will be entered into the system and the results will be evaluated.

Locations